Exact Sciences
Molecular diagnostics leader focused on cancer screening and precision oncology.
Typical Backgrounds
Types of experience professionals commonly develop
Roles Companies Often Recruit
Common roles when hiring Exact Sciences-caliber talent
- Principal Scientists
- Clinical Development Leaders
- Regulatory Affairs
- Medical Science Liaisons
- Bioinformatics Scientists
- Executive Leadership
Related Resources
Salary guides, hiring guides, market reports and case studies
Exact Sciences and the cancer-screening diagnostics market
Exact Sciences built Cologuard into one of the most commercially successful cancer-screening tests in the U.S. market and has since expanded into precision oncology diagnostics through its Oncotype DX and Ashion acquisitions. That combination of consumer-facing screening commercialization and precision oncology molecular diagnostics gives its alumni a distinctive dual skill set rarely found in one company.
Recruits Lab sees the strongest demand for Exact Sciences talent in molecular diagnostics assay development and in commercial operations for consumer-directed cancer screening, since Cologuard's direct-to-consumer marketing and physician-outreach model is genuinely different from typical B2B diagnostics sales.
Org structure and titles that matter
Exact Sciences organizes around Assay Development/R&D, Clinical Development and Medical Affairs, Regulatory Affairs, and a large Commercial organization split between screening (Cologuard) and precision oncology (Oncotype DX) product lines. Titles to know: Director of Assay Development, Director of Clinical Affairs, Director of Regulatory Affairs (LDT and IVD pathways), and Regional Sales Director within the precision oncology commercial team.
Because Exact Sciences runs both a mass-market screening test and a specialized oncology diagnostic, its Commercial titles carry meaningfully different skill sets depending on which product line they sit under, something recruiters should map carefully rather than assume is interchangeable.
Hiring bar and interview process
Assay development and R&D interviews are technically rigorous, often including a presentation on a past assay validation project and questions about analytical and clinical sensitivity/specificity tradeoffs, reflecting the regulatory scrutiny cancer-screening tests face. Regulatory affairs interviews probe experience with both laboratory-developed test (LDT) and traditional IVD pathways, since Exact Sciences has navigated both.
Commercial interviews for the Cologuard screening team weigh consumer marketing and physician-relationship skills together, while precision oncology sales interviews focus more narrowly on oncologist-facing clinical selling experience.
Compensation posture
| Level / Function | Typical Total Comp Range | Equity Form | Notes |
|---|---|---|---|
| Director, Assay Development | $190K–$250K | Exact Sciences RSUs | Bonus target ~15% |
| Director, Regulatory Affairs (LDT/IVD) | $200K–$260K | Exact Sciences RSUs | Dual-pathway regulatory experience is scarce |
| Director, Medical Affairs | $210K–$270K | Exact Sciences RSUs | KOL relationships in GI and oncology |
| Regional Sales Director, Precision Oncology | $200K–$260K base + variable | Exact Sciences RSUs | Variable comp can push total well above base |
| Director, Consumer Marketing (Cologuard) | $190K–$250K | Exact Sciences RSUs | Rare consumer marketing skill inside a diagnostics company |
Which profiles transfer well, and where
A strong transition out of Exact Sciences is a Director of Regulatory Affairs with both LDT and IVD pathway experience moving to an earlier-stage diagnostics company that needs to choose its regulatory strategy before its first product launch, a decision with major downstream commercial implications.
| Origin Team | Strengths | Best-Fit Destination | Watch-Outs |
|---|---|---|---|
| Assay Development, Molecular Diagnostics | Analytical and clinical validation rigor for regulated tests | Diagnostics startup building its first LDT or IVD product | Startup timelines may compress validation work Exact Sciences would run longer |
| Regulatory Affairs (LDT/IVD) | Dual-pathway regulatory strategy experience | Diagnostics company deciding between LDT and FDA-cleared IVD routes | Every product's clinical claims change the right regulatory strategy |
| Consumer Marketing (Cologuard) | Direct-to-consumer health marketing at scale | Consumer-facing health screening or diagnostics startup | B2B diagnostics companies won't need this skill set as directly |
| Precision Oncology Sales | Oncologist-facing clinical selling and evidence-based detailing | Precision oncology diagnostics or biotech commercial team | Requires deep clinical fluency beyond typical medtech sales training |
How to recruit out of Exact Sciences
Motivators: interest in earlier-stage equity upside and broader scope at a smaller diagnostics company, since Exact Sciences' large commercial organization can mean narrower regional or product-line roles. Blockers: strong variable compensation for high-performing sales staff that is hard to replicate at an earlier-stage company without proven revenue.
Exact Sciences' Madison, WI headquarters anchors lab and R&D staff on-site, while commercial teams are largely field-based and used to remote work already. Counter-offers for top sales performers can be aggressive given variable comp upside; recruiters should model realistic first-year ramp expectations at a startup rather than assume a like-for-like comp match.
Frequently asked questions
Why is Exact Sciences regulatory affairs talent valuable across diagnostics companies?
Exact Sciences has navigated both laboratory-developed test and traditional FDA IVD regulatory pathways for cancer screening and oncology products, giving its regulatory staff dual-pathway strategy experience that most diagnostics startups need before choosing their own path to market.
How does Exact Sciences' consumer marketing differ from typical diagnostics marketing?
Cologuard is marketed directly to consumers alongside physician outreach, unlike most diagnostics products sold purely B2B to labs or health systems. That consumer marketing experience is distinctive and valuable to any diagnostics or health-screening company building a direct-to-patient channel.
What should recruiters know about Exact Sciences' precision oncology sales comp?
Regional Sales Directors on the Oncotype DX or precision oncology team often carry meaningful variable compensation tied to hitting territory targets, which can push total comp well above base. Recruiters should model realistic ramp time before assuming a startup can match total comp immediately.
Is Exact Sciences assay development experience relevant to non-oncology diagnostics companies?
Yes. The core skills, analytical and clinical validation rigor for regulated molecular tests, transfer to any diagnostics company building assays under FDA or CLIA oversight, regardless of the specific disease area.
What functions is Exact Sciences expanding right now?
Exact Sciences continues to invest in its precision oncology diagnostics portfolio following the Ashion and Base Genomics acquisitions, driving hiring in molecular pathology, bioinformatics, and oncology-focused commercial roles alongside its established Cologuard screening business.